CARL
NASDAQ
$11.33
Carlsmed Inc (CARL)
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. The company is headquartered in Carlsbad, California.
Sector:
Healthcare
Industry:
Health Information Services
Strong Buy
Target: $18.60 (+64.17%)
Market Cap
$301M
Free Cash Flow Yield
-14.92%
Beta (5Y)
1.15
Price Chart
Valuation
Market Cap$301M
P/S5.34
P/B3.19
Profitability
Total Revenue (TTM)$56M
Gross Profit (TTM)$43M
EBITDA-$34M
Profit Margin-54%
Operating Margin-57.6%
EPS-$1.11
Financial Health
Debt-to-Equity16.7%
Free Cash Flow Yield-14.92%
Growth & Risk
Beta (5Y)1.15
Sharpe Ratio-0.03